Allfunds Group plc
Allfunds Group plc (ALLFG.AS) Financial Performance & Income Statement Overview
Review Allfunds Group plc (ALLFG.AS) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Allfunds Group plc (ALLFG.AS) Income Statement & Financial Overview
Review Allfunds Group plc ALLFG.AS income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $323.06M | $309.94M | $279.70M | $765.08M |
| Cost of Revenue | $87.99M | $93.42M | $77.30M | $637.84M |
| Gross Profit | $235.06M | $216.53M | $202.40M | $127.23M |
| Gross Profit Ratio | $0.73 | $0.70 | $0.72 | $0.17 |
| R&D Expenses | $0.00 | $0.00 | $2.64M | $2.64M |
| SG&A Expenses | $108.29M | $75.23M | $77.13M | $0.00 |
| Operating Expenses | $108.29M | $75.23M | $65.48M | $65.48M |
| Total Costs & Expenses | -$196.28M | $215.90M | $187.59M | $703.33M |
| Interest Income | $0.00 | $0.00 | $0.00 | $20.78M |
| Interest Expense | $0.00 | $0.00 | $9.41M | $0.00 |
| Depreciation & Amortization | $87.37M | $93.12M | $77.13M | $17.35M |
| EBITDA | $214.15M | $187.17M | $169.23M | $89.43M |
| EBITDA Ratio | $0.66 | $0.60 | $0.61 | $0.12 |
| Operating Income | $126.78M | $94.05M | $92.11M | $72.08M |
| Operating Income Ratio | $0.39 | $0.30 | $0.33 | $0.09 |
| Other Income/Expenses (Net) | -$275.02M | -$16.56M | $9.86M | -$31.11M |
| Income Before Tax | -$148.25M | $77.49M | $81.94M | $40.97M |
| Income Before Tax Ratio | -$0.46 | $0.25 | $0.29 | $0.05 |
| Income Tax Expense | $51.57M | $46.18M | $34.75M | $17.37M |
| Net Income | -$199.82M | $15.65M | $47.19M | $23.60M |
| Net Income Ratio | -$0.62 | $0.05 | $0.17 | $0.03 |
| EPS | -$0.33 | $0.05 | $0.08 | $0.04 |
| Diluted EPS | -$0.33 | $0.05 | $0.08 | $0.04 |
| Weighted Avg Shares Outstanding | $601.19M | $619.03M | $611.59M | $609.38M |
| Weighted Avg Shares Outstanding (Diluted) | $601.19M | $619.03M | $611.59M | $609.37M |
Over the past four quarters, Allfunds Group plc demonstrated steady revenue growth, increasing from $765.08M in Q3 2023 to $323.06M in Q4 2024. Operating income reached $126.78M in Q4 2024, maintaining a consistent 39% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $214.15M, reflecting operational efficiency. Net income dropped to -$199.82M, with EPS at -$0.33. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan